Abiopharma

🔍 Lamba Sanjiv (Director)

Company: LINDE PLC (LIN)

Report Date: 2026-03-09

Detailed Transactions and Holdings:

• Acquired 19,892 shares of Ordinary Shares (Direct)
  Date: 2026-03-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 110,686.19 | transaction_form_type: 4 | Footnotes: F1
• Sold 9,218 shares of Ordinary Shares at $484.74 per share (Direct)
  Date: 2026-03-09 | Code: F | equity_swap_involved: 0 | shares_owned_after: 101,468.19 | transaction_form_type: 4 | Footnotes: F2
• Acquired 7,015 shares of Ordinary Shares (Direct)
  Date: 2026-03-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 108,483.19 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,251 shares of Ordinary Shares at $484.74 per share (Direct)
  Date: 2026-03-09 | Code: F | equity_swap_involved: 0 | shares_owned_after: 105,232.19 | transaction_form_type: 4 | Footnotes: F2
• Acquired 7,015 shares of Ordinary Shares (Direct)
  Date: 2026-03-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 112,247.19 | transaction_form_type: 4 | Footnotes: F3
• Sold 3,086 shares of Ordinary Shares at $484.74 per share (Direct)
  Date: 2026-03-09 | Code: F | equity_swap_involved: 0 | shares_owned_after: 109,161.19 | transaction_form_type: 4 | Footnotes: F2
• Acquired 19,892 shares of Performance Share Units (ROC) (Derivative)
  Date: 2026-03-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,892.00 | transaction_form_type: 4 | Footnotes: F4, F5, F5
• Sold 19,892 shares of Performance Share Units (ROC) (Derivative)
  Date: 2026-03-09 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F5, F5
• Acquired 7,015 shares of Performance Share Units (RTSR) (Derivative)
  Date: 2026-03-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,015.00 | transaction_form_type: 4 | Footnotes: F4, F6, F6
• Sold 7,015 shares of Performance Share Units (RTSR) (Derivative)
  Date: 2026-03-09 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F6, F6
• Acquired 7,328 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,328.00 | transaction_form_type: 4 | Footnotes: F4, F7, F7
• Sold 7,015 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-09 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F10, F10
• Acquired 59,746 shares of Stock Options (right to buy) at $483.62 per share (Derivative)
  Date: 2026-03-09 | Code: A | Expires: 2036-03-09 | equity_swap_involved: 0 | shares_owned_after: 59,746.00 | transaction_form_type: 4 | Footnotes: F11
• Holds 6,364 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-09 | Code: H | shares_owned_after: 6,364.00 | Footnotes: F4, F8, F8
• Holds 6,405 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-09 | Code: H | shares_owned_after: 6,405.00 | Footnotes: F4, F9, F9
• Holds 44,696 shares of Stock Options (right to buy) at $468.77 per share (Derivative)
  Date: 2026-03-09 | Code: H | Expires: 2035-03-07 | shares_owned_after: 44,696.00 | Footnotes: F12
• Holds 41,530 shares of Stock Options (right to buy) at $465.29 per share (Derivative)
  Date: 2026-03-09 | Code: H | Expires: 2034-03-07 | shares_owned_after: 41,530.00 | Footnotes: F13
• Holds 46,365 shares of Stock Options (right to buy) at $354.14 per share (Derivative)
  Date: 2026-03-09 | Code: H | Expires: 2033-03-07 | shares_owned_after: 46,365.00 | Footnotes: F14
• Holds 54,920 shares of Stock Options (right to buy) at $270.99 per share (Derivative)
  Date: 2026-03-09 | Code: H | Expires: 2032-03-07 | shares_owned_after: 54,920.00 | Footnotes: F15
• Holds 40,995 shares of Stock Options (right to buy) at $253.68 per share (Derivative)
  Date: 2026-03-09 | Code: H | Expires: 2031-03-08 | shares_owned_after: 40,995.00 | Footnotes: F16
• Holds 37,565 shares of Stock Options (right to buy) at $173.13 per share (Derivative)
  Date: 2026-03-09 | Code: H | Expires: 2030-03-09 | shares_owned_after: 37,565.00 | Footnotes: F17
• Holds 15,470 shares of Stock Options (right to buy) at $176.63 per share (Derivative)
  Date: 2026-03-09 | Code: H | Expires: 2029-03-20 | shares_owned_after: 15,470.00 | Footnotes: F18
• Holds 546 shares of Deferred Stock Units (Derivative)
  Date: 2026-03-09 | Code: H | shares_owned_after: 546.35 | Footnotes: F4, F19, F19

Footnotes:

• F1: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023.
• F2: Ordinary shares withheld from the payout to cover tax withholdings.
• F3: Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2023.
• F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis.
• F5: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
• F6: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against RTSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
• F7: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.
• F8: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
• F9: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
• F10: Restricted Stock Units that vested in full and paid out on March 9, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
• F11: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.
• F12: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
• F13: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
• F14: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
• F15: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
• F16: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
• F17: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
• F18: This option vests over three years in three consecutive equal annual installments beginning March 20, 2020.
• F19: Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.